Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | 2C16H31O2.Mg |
| Molecular Weight | 535.1373 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Mg++].CCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCC([O-])=O
InChI
InChIKey=ABSWXCXMXIZDSN-UHFFFAOYSA-L
InChI=1S/2C16H32O2.Mg/c2*1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18;/h2*2-15H2,1H3,(H,17,18);/q;;+2/p-2
| Molecular Formula | Mg |
| Molecular Weight | 24.305 |
| Charge | 2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C16H31O2 |
| Molecular Weight | 255.4161 |
| Charge | -1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Studies on the biofilm produced by Pseudomonas aeruginosa grown in different metal fatty acid salt media and its application in biodegradation of fatty acids and bioremediation of heavy metal ions. | 2017-01 |
|
| Quantitative study on the effect of calcium and magnesium palmitate on the formation of Pseudomonas aeruginosa biofilm. | 2016-12 |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26226897
M9 minimal media with 1% (w/w) magnesium palmitate (Media M2) was used
for the growth of Pseudomonas aeruginosa biofilms.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:02:25 GMT 2025
by
admin
on
Mon Mar 31 21:02:25 GMT 2025
|
| Record UNII |
JJ0UR696JR
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
9850060
Created by
admin on Mon Mar 31 21:02:25 GMT 2025 , Edited by admin on Mon Mar 31 21:02:25 GMT 2025
|
PRIMARY | |||
|
SUB116307
Created by
admin on Mon Mar 31 21:02:25 GMT 2025 , Edited by admin on Mon Mar 31 21:02:25 GMT 2025
|
PRIMARY | |||
|
1424873
Created by
admin on Mon Mar 31 21:02:25 GMT 2025 , Edited by admin on Mon Mar 31 21:02:25 GMT 2025
|
PRIMARY | RxNorm | ||
|
220-010-0
Created by
admin on Mon Mar 31 21:02:25 GMT 2025 , Edited by admin on Mon Mar 31 21:02:25 GMT 2025
|
PRIMARY | |||
|
2601-98-1
Created by
admin on Mon Mar 31 21:02:25 GMT 2025 , Edited by admin on Mon Mar 31 21:02:25 GMT 2025
|
PRIMARY | |||
|
JJ0UR696JR
Created by
admin on Mon Mar 31 21:02:25 GMT 2025 , Edited by admin on Mon Mar 31 21:02:25 GMT 2025
|
PRIMARY | |||
|
100000142254
Created by
admin on Mon Mar 31 21:02:25 GMT 2025 , Edited by admin on Mon Mar 31 21:02:25 GMT 2025
|
PRIMARY | |||
|
JJ0UR696JR
Created by
admin on Mon Mar 31 21:02:25 GMT 2025 , Edited by admin on Mon Mar 31 21:02:25 GMT 2025
|
PRIMARY | |||
|
DTXSID80890562
Created by
admin on Mon Mar 31 21:02:25 GMT 2025 , Edited by admin on Mon Mar 31 21:02:25 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |